News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ligand Pharmaceuticals Inc. (LGND) Agrees To Sell X-Ceptor Therapeutics, Inc. Interest And To Vote Its X-Ceptor Shares In Favor Of Recently Announced Merger Of Exelixis, Inc. (EXEL) And X-Ceptor



10/19/2005 5:09:18 PM

Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) announced today that the company agreed to exchange its X-Ceptor shares in the recently announced merger between Exelixis Inc. (Nasdaq:EXEL) and X-Ceptor Therapeutics, Inc. for Exelixis common stock. In connection with the proposed merger, Ligand agreed to vote its X-Ceptor shares in favor of the merger.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES